Skip to content

a study in people with moderate acne comparing daily isotretinoin with 10 days a month isotretinoin to see which clears acne better and has fewer side effects.

A study on Efficacy of conventional and Pulse isotretinoin therapy in moderate Acne Vulgaris Patients in a Tertiary care centre , Chengalpattu Randomized control trial. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095160
Enrollment
104
Registered
2025-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: randomized control trial: 2 arm study on oral isotretinoin therapy . Group A : pulse therapy for 12 weeks and Group B : conventional therapy for 12 weeks Control Intervention1: oral is

Sponsors

Karpaga Vinayaga Institute Of Medical Sciences And Research Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with acne vulgaris on face more than equal to 18 yrs with moderate grade, who understands the protocol and willing to give informed consent

Exclusion criteria

Exclusion criteria: patient who are tring to conceive , pregnant , breast feeding , with deranged liver function test and renal function test ,allergic to isotretinoin ,dyslipidemia .

Design outcomes

Primary

MeasureTime frame
percentage improvement , patient satisfaction.Timepoint: percentage of improvement assessed at 2,4,8,12 ,16and 20 weeks . patient satisfaction assessed at 20 week.

Secondary

MeasureTime frame
1.Liver function test , 2. Lipid function test , 3.Patient satisfaction , 4.Clinical photographs at before & after treatment .Timepoint: 1.changes in AST & ALT measuring at 6, 12, 20 week. 2.changes in cholesterol, triglycerides, LDL, HDL measured at 6, 12 ,20 weeks 3.measured at 20 week using likert scale, 4.Clinical photographs at base line & at 20 week treatment .

Countries

India

Contacts

Public ContactDr Bhagya M Baiju

Karpaga Vinayaga Institute Of Medical Sciences And Research Center

drselvasudha@gmail.com9445093599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026